(0.27%) 5 145.25 points
(0.18%) 38 511 points
(0.39%) 17 915 points
(-0.12%) $83.75
(0.31%) $1.929
(0.14%) $2 350.50
(0.16%) $27.58
(1.95%) $940.10
(-0.13%) $0.933
(-0.30%) $10.99
(-0.29%) $0.798
(1.29%) $93.06
Live Chart Being Loaded With Signals
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally...
Stats | |
---|---|
Šios dienos apimtis | 4 023.00 |
Vidutinė apimtis | 8 710.00 |
Rinkos kapitalizacija | 509.33M |
EPS | €0 ( 2024-03-28 ) |
Kita pelno data | ( €0 ) 2024-06-07 |
Last Dividend | €0.970 ( 2023-05-18 ) |
Next Dividend | €0 ( N/A ) |
P/E | 39.16 |
ATR14 | €0.203 (0.48%) |
Tūris Koreliacija
Stratec SE Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Stratec SE Koreliacija - Valiuta/Žaliavos
Stratec SE Finansinės ataskaitos
Annual | 2023 |
Pajamos: | €261.91M |
Bruto pelnas: | €64.85M (24.76 %) |
EPS: | €1.080 |
FY | 2023 |
Pajamos: | €261.91M |
Bruto pelnas: | €64.85M (24.76 %) |
EPS: | €1.080 |
FY | 2022 |
Pajamos: | €274.63M |
Bruto pelnas: | €79.49M (28.94 %) |
EPS: | €2.41 |
FY | 2021 |
Pajamos: | €287.34M |
Bruto pelnas: | €87.71M (30.53 %) |
EPS: | €3.30 |
Financial Reports:
No articles found.
Stratec SE Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0.970 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.0267 | 2004-05-17 |
Last Dividend | €0.970 | 2023-05-18 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | €11.02 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.94 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.98 | |
Div. Directional Score | 7.45 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
GRM.DE | Ex Dividend Knight | 2023-07-07 | Quarterly | 0 | 0.00% | |
PUM.DE | Ex Dividend Junior | 2023-05-25 | Annually | 0 | 0.00% | |
BMW.DE | Ex Dividend Junior | 2023-05-12 | Annually | 0 | 0.00% | |
INN1.DE | Ex Dividend Junior | 2023-08-07 | Semi-Annually | 0 | 0.00% | |
SWF.DE | Ex Dividend Junior | 2023-09-01 | Quarterly | 0 | 0.00% | |
CVS.DE | Ex Dividend Knight | 2023-10-19 | Quarterly | 0 | 0.00% | |
LUS1.DE | Ex Dividend Junior | 2023-06-23 | Annually | 0 | 0.00% | |
2M6.DE | Ex Dividend Knight | 2023-09-21 | Quarterly | 0 | 0.00% | |
VFP.DE | Ex Dividend Junior | 2023-09-08 | Quarterly | 0 | 0.00% | |
ENI.F | Ex Dividend Knight | 2023-11-20 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0499 | 1.500 | 9.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0272 | 1.200 | 9.09 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0573 | 1.500 | -0.474 | -0.711 | [0.1 - 1] |
payoutRatioTTM | 0.0000765 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 2.54 | 0.800 | 2.28 | 1.823 | [1 - 3] |
quickRatioTTM | 1.044 | 0.800 | 8.57 | 6.85 | [0.8 - 2.5] |
cashRatioTTM | 0.348 | 1.500 | 9.18 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.267 | -1.500 | 5.56 | -8.34 | [0 - 0.6] |
interestCoverageTTM | 5.82 | 1.000 | 8.95 | 8.95 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.598 | 2.00 | 9.47 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.165 | 2.00 | 9.92 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.548 | -1.500 | 7.81 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.248 | 1.000 | 9.21 | 9.21 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0887 | 1.000 | -0.225 | -0.225 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.152 | 1.000 | -0.267 | -0.267 | [0.2 - 2] |
assetTurnoverTTM | 0.546 | 0.800 | 9.69 | 7.75 | [0.5 - 2] |
Total Score | 10.92 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 38.75 | 1.000 | 6.19 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0573 | 2.50 | -0.305 | -0.711 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.165 | 2.00 | 9.95 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.33 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.598 | 2.00 | 9.47 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0000765 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0742 | 1.000 | -0.646 | 0 | [0.1 - 0.5] |
Total Score | 3.98 |
Stratec SE
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.